Concepedia

Elderly patients with advanced colorectal cancer derive similar benefit without excessive toxicity after first-line chemotherapy with oxaliplatin-based combinations: Comparative outcomes from the 03-TTD-01 phase III study

Javier Sastre, Enrique Aranda, Bartomeu Massutí, Josep Tabernero, Manuel Chaves-Conde, Albert Abad, Alfredo Carrato, Juan José Reina, Bernardo Queralt, Auxiliadora Gómez‐España,

Critical Reviews in Oncology/Hematology · 2008 · 50 citations · 18 references

DOI

Concepts

References

18

Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials

Laura F. Hutchins, Joseph M. Unger, John J. Crowley et al. · New England Journal of Medicine · 1999 · 2.2K citations

, , +13

Pooled Analysis of Safety and Efficacy of Oxaliplatin Plus Fluorouracil/Leucovorin Administered Bimonthly in Elderly Patients With Colorectal Cancer

Richard M. Goldberg, Isabelle Tabah-Fisch, Harry Bleiberg et al. · Journal of Clinical Oncology · 2006 · 468 citations

, , +17

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Continuous-Infusion Fluorouracil Plus Oxaliplatin As First-Line Therapy in Metastatic Colorectal Cancer: Final Report of the Spanish Cooperative Group for the Treatment of Digestive Tumors Trial

Eduardo Díaz‐Rubio, Josep Tabernero, Auxiliadora Gómez‐España et al. · Journal of Clinical Oncology · 2007 · 269 citations · Full text

, , +11

Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials

Gunnar Folprecht, David Cunningham, Paul J. Ross et al. · Annals of Oncology · 2004 · 258 citations · Full text

, , +12

Survival of colorectal cancer patients in Europe during the period 1978–1989

Gemma Gatta, Jean Faivre, Riccardo Capocaccia et al. · European Journal of Cancer · 1998 · 155 citations · Full text

, , +14